Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 10,334 | 5,687 | 3,809 | 2,320 | 1,944 |
| Cost of Goods | 4,250 | 2,484 | 1,517 | 1,026 | 884 |
| Gross Profit | 6,084 | 3,203 | 2,292 | 1,294 | 1,060 |
| Operating Expenses | 9,489 | 6,703 | 5,035 | 4,189 | 5,365 |
| Operating Income | -3,155 | -3,016 | -2,226 | -2,869 | -3,421 |
| Interest Expense | 195 | 172 | 302 | 172 | 42 |
| Other Income | -54 | -230 | -70 | 9 | 375 |
| Pre-tax Income | -3,404 | -3,418 | -2,598 | -3,032 | -3,088 |
| Income Tax | -225 | -93 | -1,789 | N/A | N/A |
| Net Income Continuous | -3,179 | -3,325 | -809 | -3,032 | -3,088 |
| Minority Interests | 241 | 77 | N/A | N/A | N/A |
| Net Income | $-3,420 | $-3,402 | $-809 | $-3,032 | $-3,088 |
| EPS Basic Total Ops | -0.45 | -0.50 | -0.18 | -0.54 | -0.81 |
| EPS Basic Continuous Ops | -0.42 | -0.49 | -0.14 | -0.56 | -0.80 |
| EPS Diluted Total Ops | -0.45 | -0.50 | -0.18 | -0.54 | -0.81 |
| EPS Diluted Continuous Ops | -0.42 | -0.49 | -0.14 | -0.56 | -0.80 |
| EPS Diluted Before Non-Recurring Items | -0.45 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-2,955 | $-2,819 | $-1,892 | $-2,586 | $-3,209 |